Search Results - "DiBacco, A"

227 Association of K-Ras Genotype with Xenograft Tumor Response to the Investigational Proteasome Inhibitor MLN9708 by Chattopadhyay, N, DiBacco, A, Garnsey, J, Bannerman, B, Hales, P, Yu, J, Mulligan, G, Koenig, E, Berger, A, Manfredi, M

Get full text

The indirect effects of state experiential avoidance on trait experiential avoidance and negative affect in the moment by Lewis, Meaghan M., Naugle, Amy E., Katte, Kyra, DiBacco, Tabitha A.

“…Because experiential avoidance is considered by some to be the root of most forms of psychopathology, it is often a primary intervention and research target…”
Get full text

Behavioral Measures of Experiential Avoidance: The Role of Context in Predicting Performance on Two Stressful Tasks by Lewis, Meaghan M., Naugle, Amy E., DiBacco, Tabitha A., Katte, Kyra, Smith, Callum A., Blematl, Audrey R.

“…Experiential avoidance (EA) is considered a key factor in human suffering. However, research in this area is often based on self-report measures with…”
Get full text

Tumour growth fraction and apoptosis in salivary gland acinic cell carcinomas. Prognostic implications of Ki-67 and bcl-2 expression and of in situ end labelling (TUNEL) by Hellquist, Henrik B., Sundelin, Kaarina, Di Bacco, Alessandra, Tytor, Macie, Manzotti, Michela, Viale, Giuseppe

“…bcl‐2 protein and Ki‐67 (MIB‐1) were studied in 32 acinic cell carcinomas (ACCs), all with a minimum of 5 years' clinical follow‐up. Tumour apoptosis was…”
Get full text

NXP-2 Association with SUMO-2 Depends on Lysines Required for Transcriptional Repression by Rosendorff, Adam, Sakakibara, Shuhei, Lu, Sixin, Kieff, Elliott, Xuan, Yan, DiBacco, Alessandra, Shi, Yujiang, Shi, Yang, Gill, Grace

“…Small ubiquitin-like modifier (SUMO) modification of transcription factors is generally associated with repression. Reverse genetic analysis of SUMO-1, and-2…”
Get full text

Ixazomib, an Investigational Oral Proteasome Inhibitor (PI), in Combination with Lenalidomide and Dexamethasone (IRd), Significantly Extends Progression-Free Survival (PFS) for Patients (Pts) with Relapsed and/or Refractory Multiple Myeloma (RRMM): The Phase 3 Tourmaline-MM1 Study (NCT01564537) by Moreau, Philippe, Masszi, Tamás, Grzasko, Norbert, Bahlis, Nizar J, Hansson, Markus, Pour, Ludek, Sandhu, Irwindeep, Ganly, Peter, Baker, Bartrum W, Jackson, Sharon, Stoppa, Anne-Marie, Simpson, David R, Gimsing, Peter, Palumbo, Antonio, Garderet, Laurent, Cavo, Michele, Kumar, Shaji K., Touzeau, Cyrille, Buadi, Francis, Laubach, Jacob P., Lin, Jianchang, Berg, Deborah, DiBacco, Alessandra, Hui, Ai-Min, Richardson, Paul G.

“…▪ Background Ixazomib is the first orally administered PI studied in the clinic. The feasibility of combining ixazomib weekly and lenalidomide-dexamethasone…”
Get full text

Prolonged Exposure Therapy: A Case of Comorbid PTSD, ADHD, and GAD by DiBacco, Tabitha A., Gaynor, Scott T.

“…This case study displays the successful application of Prolonged Exposure (PE) for a client with diagnoses of Posttraumatic Stress Disorder (PTSD), Attention…”
Get full text

Prognostic and predictive value of tumour angiogenesis in ovarian carcinomas by Gasparini, Giampietro, Bonoldi, Emanuela, Viale, Giuseppe, Verderio, Paolo, Boracchi, Patrizia, Panizzoni, Gino A., Radaelli, Umberto, Di Bacco, Alessandra, Guglielmi, Rosa B., Bevilacoua, Pierantonio

“…Experimental studies suggest that angiogenesis plays an important role in the pathogenesis of ascites and progression of ovarian cancer. To evaluate the…”
Get full text

Angiogenesis in primary lung cancer and lung secondaries by Pezzella, F., Di Bacco, A., Andreola, S., Nicholson, A.G., Pastorino, U., Harris, A.L.

Get full text

The combined evaluation of p53 accumulation and of Ki-67 (MIB1) labelling index provides independent information on overall survival of ovarian carcinoma patients by VIALE, G, MAISONNEUVE, P, BONOLDI, E, DI BACCO, A, BEVILACQUA, P, PANIZZONI, G. A, RADAELLI, U, GASPARINI, G

“…The prognostic implications of p53 accumulation, bcl-2 immunoreactivity and tumour proliferative fraction in ovarian carcinomas are still debated. One hundred…”
Get full text